Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,178,165
+$507,863 QoQ
Shares Held
1,816
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,411
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $46,475,498 across 14 Drug Manufacturers - General names. LLY ranks #4 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
118,345 | $15,207,332 | |
| 2 | JNJ |
Johnson & Johnson
|
58,033 | $14,738,640 | |
| 3 | AMGN |
Amgen Inc
|
28,143 | $10,191,142 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
1,816 | $2,178,165 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,971 | $1,638,755 | |
| 6 | ABBV |
AbbVie Inc.
|
5,799 | $1,459,260 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,952 | $342,954 | |
| 8 | NVO |
Novo Nordisk A S
|
4,826 | $231,358 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,178,165 | 1,816 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,670,302 | 1,816 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,859,196 | 1,730 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,319,990 | 1,730 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,347,027 | 1,728 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,427,172 | 1,728 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,417,392 | 1,836 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,637,217 | 1,848 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,592,563 | 1,759 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,364,541 | 1,754 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,569,220 | 2,692 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,946,559 | 3,624 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,197,640 | 4,686 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,719,847 | 5,008 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $445,593 | 1,218 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $395,780 | 1,224 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $409,178 | 1,262 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $360,539 | 1,259 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $359,914 | 1,303 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $300,827 | 1,302 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $742,726 | 3,236 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $642,100 | 3,437 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $529,482 | 3,136 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $471,443 | 3,185 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $514,540 | 3,134 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $434,748 | 3,134 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||